CHAMPIONS ONCOLOGY, INC. (CSBR)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Apr 30
In fiscal 2025, CHAMPIONS ONCOLOGY, INC. reported revenue of $56.94M, up 13.5% from the prior year. The company was profitable, with a net margin of 8.3%. It held $32.34M in total assets against $28.57M in total liabilities.
Key ratios (FY2025)
8.0%
Operating margin
8.3%
Net margin
124.6%
Return on equity
+13.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $56.94M | $50.16M | $53.87M | $49.11M | $41.04M | $32.12M | $27.07M | $20.24M | — | — |
| Cost of Revenue | $28.39M | $29.40M | $29.53M | $23.63M | $21.45M | $17.00M | — | — | — | — |
| Operating Income | $4.55M | -$7.36M | -$5.26M | $607.0K | $366.0K | -$1.92M | $270.0K | -$1.35M | -$6.81M | -$10.32M |
| Net Income | $4.70M | -$7.28M | -$5.33M | $548.0K | $362.0K | -$2.09M | $128.0K | -$1.48M | -$6.88M | -$10.45M |
| EPS (Diluted) | $0.33 | $-0.54 | $-0.39 | $0.04 | $0.02 | $-0.18 | $0.01 | $-0.13 | — | $-1.20 |
| Total Assets | $32.34M | $26.13M | $34.31M | $35.38M | $27.59M | $20.75M | $11.27M | $8.08M | $8.01M | $5.78M |
| Total Liabilities | $28.57M | $28.04M | $29.68M | $26.28M | $20.16M | $15.65M | $9.03M | $8.07M | $7.61M | $5.54M |
| Shareholders' Equity | $3.77M | -$1.90M | $4.64M | $9.10M | $7.43M | $5.10M | $2.14M | $3.0K | $400.0K | $238.0K |
| Cash & Equivalents | — | — | — | — | — | — | $3.24M | $856.0K | $3.29M | $2.58M |
| Operating Cash Flow | $7.39M | -$6.14M | $3.97M | $6.50M | -$1.68M | $2.90M | $1.86M | -$1.23M | -$2.84M | -$6.41M |
| Capital Expenditures | $389.0K | $836.0K | $2.87M | $2.38M | $3.28M | $2.22M | $834.0K | $1.23M | $766.0K | $322.0K |
| Shares Outstanding | 13.78M | 13.59M | 13.54M | 13.52M | 13.41M | 12.73M | 11.62M | 11.00M | 10.98M | 8.70M |